EUVIMEDEUVIMED entdecken
Crossref

SMPD3 Inhibition Contributes to Nicotinamide-Ameliorated Hepatic Steatosis in Chronic Alcohol-Fed Mice

Qinchao Ding iD, Wenjing Cao iD, Xinxuan Ge iD, Feiwei Cao, Qing Song, Yue Jin, Tianchi Sun, Haoyi Fang, Jiaxin Li, Songtao Li iD

Journal of Agricultural and Food Chemistry · 02.07.2025 · 73 (26) · 16370-16383

DOI: 10.1021/acs.jafc.5c01450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 22.05.2025. Verfasst von Qinchao Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P. R. China. Hauptthemen laut MEDLINE: Niacinamide, Sphingomyelin Phosphodiesterase, Ethanol, Fatty Liver. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcohol-associated liver disease (ALD) is characterized by the reduction of hepatic nicotinamide adenine dinucleotide (NAD+), which exacerbates hepatic steatosis. The present study was conducted to investigate the protective role of nicotinamide (NAM), a foodborne precursor of NAD+ biosynthesis, in ALD. C57BL/6N mice were employed to establish the ALD model and were administered NAM by gavage. Our results showed that NAM supplementation significantly ameliorated alcohol-induced NAD+ reduction and lipid accumulation in both mice liver and cultured AML-12 hepatocytes and improved lipid metabolism-associated gene disorders. Alcohol-induced liver injury and oxidative stress were also blocked by NAM administration. Further transcriptomics analysis and validation revealed that alcohol-stimulated sphingomyelin phosphodiesterase 3 (SMPD3) was significantly reversed by NAM, along with the reduction of hepatic ceramide levels. Importantly, SMPD3 was upregulated in the livers of ALD patients. Genetically silencing SMPD3 alleviated alcohol-induced lipid accumulation in hepatocytes. ChIP assay identified SMPD3 as a direct downstream target of hypoxia-inducible factor 1 alpha (HIF-1α). Liver-specific Hif1α knockdown reduced the level of hepatic SMPD3 expression in mice. Activation of HIF-1α abolished the prevention of intrahepatic liver lipid deposition by NAM, while SMPD3 knockdown reversed HIF-1α activation-stimulated lipid accumulation, indicating that a HIF-1α-regulated SMPD3 pathway was involved in the beneficial role of NAM. NAM improved liver oxidative stress, while antioxidant MitoQ administration rescued HIF-1α/SMPD3 activation in ALD mice, implying that the antioxidant effect of NAM contributed to its inhibitory role on the HIF-1α/SMPD3 pathway. In conclusion, NAM ameliorates chronic alcohol intake-induced hepatic steatosis by inhibiting SMPD3. This study provides new insights into the mechanistic understanding of ALD and highlights NAM as a therapeutic choice for ALD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NiacinamideSphingomyelin PhosphodiesteraseEthanolFatty LiverAnimalsMiceMice, Inbred C57BLMaleHepatocytesHumansHypoxia-Inducible Factor 1, alpha SubunitLiverLipid MetabolismOxidative StressDisease Models, Animal

Stichwörter der Autor:innen

alcohol-associated liver diseasehepatic steatosishypoxia-inducible factor 1 alphanicotinamidesphingomyelin phosphodiesterase 3

Substanzen

NiacinamideSphingomyelin PhosphodiesteraseHypoxia-Inducible Factor 1, alpha SubunitEthanol

Autor:innen und Institutionen

  • School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P. R. China.
  • Division of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China.

ORCID-Profile: Qinchao Ding, Wenjing Cao, Xinxuan Ge, Songtao Li

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Zhejiang Chinese Medical University

Zitieren

APA

Ding, Q., Cao, W., Ge, X., Cao, F., Song, Q., Jin, Y., Sun, T., Fang, H., Li, J., & Li, S. (2025). SMPD3 Inhibition Contributes to Nicotinamide-Ameliorated Hepatic Steatosis in Chronic Alcohol-Fed Mice. Journal of Agricultural and Food Chemistry, 73(26), 16370-16383. https://doi.org/10.1021/acs.jafc.5c01450

Vancouver

Ding Q, Cao W, Ge X, Cao F, Song Q, Jin Y, et al. SMPD3 Inhibition Contributes to Nicotinamide-Ameliorated Hepatic Steatosis in Chronic Alcohol-Fed Mice. Journal of Agricultural and Food Chemistry. 2025;73(26):16370-16383. doi:10.1021/acs.jafc.5c01450

BibTeX
@article{Ding2025,
  author = {Ding, Qinchao and Cao, Wenjing and Ge, Xinxuan and Cao, Feiwei and Song, Qing and Jin, Yue and Sun, Tianchi and Fang, Haoyi and Li, Jiaxin and Li, Songtao},
  title = {SMPD3 Inhibition Contributes to Nicotinamide-Ameliorated Hepatic Steatosis in Chronic Alcohol-Fed Mice},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2025},
  volume = {73},
  number = {26},
  pages = {16370--16383},
  doi = {10.1021/acs.jafc.5c01450}
}
Kostenlos starten →